1. Home
  2. OPTN vs CEE Comparison

OPTN vs CEE Comparison

Compare OPTN & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • CEE
  • Stock Information
  • Founded
  • OPTN 2010
  • CEE 1990
  • Country
  • OPTN United States
  • CEE Germany
  • Employees
  • OPTN N/A
  • CEE N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • CEE Finance Companies
  • Sector
  • OPTN Health Care
  • CEE Finance
  • Exchange
  • OPTN Nasdaq
  • CEE Nasdaq
  • Market Cap
  • OPTN 92.8M
  • CEE 83.8M
  • IPO Year
  • OPTN 2017
  • CEE N/A
  • Fundamental
  • Price
  • OPTN $9.39
  • CEE $15.19
  • Analyst Decision
  • OPTN Hold
  • CEE
  • Analyst Count
  • OPTN 3
  • CEE 0
  • Target Price
  • OPTN $9.00
  • CEE N/A
  • AVG Volume (30 Days)
  • OPTN 32.1K
  • CEE 22.0K
  • Earning Date
  • OPTN 05-20-2025
  • CEE 01-01-0001
  • Dividend Yield
  • OPTN N/A
  • CEE 3.86%
  • EPS Growth
  • OPTN N/A
  • CEE N/A
  • EPS
  • OPTN N/A
  • CEE N/A
  • Revenue
  • OPTN $78,226,000.00
  • CEE N/A
  • Revenue This Year
  • OPTN $30.49
  • CEE N/A
  • Revenue Next Year
  • OPTN $13.51
  • CEE N/A
  • P/E Ratio
  • OPTN N/A
  • CEE N/A
  • Revenue Growth
  • OPTN 10.20
  • CEE N/A
  • 52 Week Low
  • OPTN $4.82
  • CEE $7.80
  • 52 Week High
  • OPTN $20.03
  • CEE $10.32
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 76.14
  • CEE 61.93
  • Support Level
  • OPTN $9.37
  • CEE $14.55
  • Resistance Level
  • OPTN $9.45
  • CEE $14.93
  • Average True Range (ATR)
  • OPTN 0.08
  • CEE 0.40
  • MACD
  • OPTN -0.07
  • CEE 0.08
  • Stochastic Oscillator
  • OPTN 80.71
  • CEE 97.79

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

Share on Social Networks: